162 related articles for article (PubMed ID: 1390339)
21. Suppression of tumorigenicity and induction of senescence on human endometrial carcinoma cell lines by transfer of normal human chromosomes.
Yamada H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1443-54. PubMed ID: 7705753
[TBL] [Abstract][Full Text] [Related]
22. Reduction of caveolin-1 expression in tumorigenic human cell hybrids.
Suzuki T; Suzuki Y; Hanada K; Hashimoto A; Redpath JL; Stanbridge EJ; Nishijima M; Kitagawa T
J Biochem; 1998 Aug; 124(2):383-8. PubMed ID: 9685730
[TBL] [Abstract][Full Text] [Related]
23. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
24. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
25. Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids.
Schneider BL; Kulesz-Martin M; Bowden GT
Mol Carcinog; 1995 May; 13(1):6-14. PubMed ID: 7766311
[TBL] [Abstract][Full Text] [Related]
26. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
[TBL] [Abstract][Full Text] [Related]
27. Genetic heterogeneity of chromosome 11 associated with tumorigenicity in HeLa D98-OR cells.
Horikawa I; Okamoto A; Yokota J; Oshimura M
Cancer Genet Cytogenet; 1995 Dec; 85(2):97-100. PubMed ID: 8548745
[TBL] [Abstract][Full Text] [Related]
28. Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11.
Coleman WB; McCullough KD; Esch GL; Civalier CJ; Livanos E; Weissman BE; Grisham JW; Smith GJ
Mol Carcinog; 1995 Aug; 13(4):220-32. PubMed ID: 7646761
[TBL] [Abstract][Full Text] [Related]
29. Oncogenes and tumor-suppressor genes.
Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
[TBL] [Abstract][Full Text] [Related]
30. Effect of retroviral integration on control of expression of a tumor marker in HeLa cells.
Gross MM; Janiaud P; Stanbridge EJ
Mol Carcinog; 1993; 8(2):89-95. PubMed ID: 7691070
[TBL] [Abstract][Full Text] [Related]
31. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
32. Detection of differentially expressed genes in HeLa x fibroblast hybrids using subtractive suppression hybridization.
Nishizuka S; Tsujimoto H; Stanbridge EJ
Cancer Res; 2001 Jun; 61(11):4536-40. PubMed ID: 11389086
[TBL] [Abstract][Full Text] [Related]
33. Examination of the oncogenic potential of H19 gene in HeLa x normal human fibroblast hybrid cells.
Tsujimoto H; Nishizuka S; Redpath LJ; Stanbridge EJ
Int J Oncol; 2001 Jul; 19(1):89-95. PubMed ID: 11408927
[TBL] [Abstract][Full Text] [Related]
34. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
35. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction.
Suzuki T; Iwazaki A; Katagiri H; Oka Y; Redpath JL; Stanbridge EJ; Kitagawa T
Eur J Biochem; 1999 Jun; 262(2):534-40. PubMed ID: 10336639
[TBL] [Abstract][Full Text] [Related]
37. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
38. Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects.
Islam MQ; Islam K
Cytogenet Cell Genet; 2000; 88(1-2):103-9. PubMed ID: 10773681
[TBL] [Abstract][Full Text] [Related]
39. Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18.
Yamada H; Sasaki M; Honda T; Wake N; Boyd J; Oshimura M; Barrett JC
Genes Chromosomes Cancer; 1995 May; 13(1):18-24. PubMed ID: 7541639
[TBL] [Abstract][Full Text] [Related]
40. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
